Medis QFR® receives PMDA Approval in Japan!
Medis QFR is now officially available for clinical use in Japan
2 mins – August 9, 2023
Today marks a milestone as we celebrate the significant achievement of securing PMDA approval for Medis QFR. With the green light from the Pharmaceuticals and Medical Devices Agency (PMDA), Medis QFR is now officially available for clinical use in Japan. This approval paves the way for the software to be widely adopted by Japanese hospitals for daily patient care, for diagnosis and decision making.
We extend our gratitude to everyone who contributed to making this a reality. This decision will bring about a revolutionary transformation in cardiovascular patient care across Japan.
Share this article on: